In 2020, Cancer Transcriptome Atlas launched a new product based on Nano String Technologies' and launched a new platform called as GeoMx Digital Spatial Profiler (DSP) platform, which is used for readout on Illumina's next-generation sequencing (NGS) technology.
Increasing Demand for Personalized Medicine
Personalized medicine is one of the key drivers of the growth of Global Spatial Genomics and Transcriptomics Market. Personalized medicine involves the use of genomic information to tailor treatments to individual patients, with the aim of improving treatment outcomes and reducing adverse effects. Spatial genomics and transcriptomics provide a more comprehensive understanding of the organization and function of genes, making it easier to develop personalized treatments for patients with complex diseases.
Spatial genomics and transcriptomics can help to identify specific genes and their expression patterns that are associated with disease, allowing for more targeted and effective therapies. This can be particularly beneficial for patients with cancer, as spatial genomics and transcriptomics can help to identify genetic changes that lead to the development and progression of cancer.
Download Free Sample ReportGrowing Prevalence of Chronic Diseases
Increasing prevalence of Chronic diseases, such as cancer, cardiovascular disease, and diabetes, are a major factor which will drive the growth of the Global Spatial Genomics and Transcriptomics Market during the forecast period. Spatial genomics and transcriptomics can help in the early detection, diagnosis, and treatment of chronic diseases, leading to better patient outcomes.
Rising Investment in Research & Development
Research & development (R&D) is a crucial factor in driving the growth of the Global Spatial Genomics and Transcriptomics Market. Advancements in technology, new product development, and increasing R&D investment are driving the growth of the market.
In addition, R&D investment is critical to the continued development of spatial genomics and transcriptomics. As the technology becomes more widely adopted, there is a growing need for new and innovative applications, and the development of new technologies that can further improve the accuracy and sensitivity of the technology. R&D investment is necessary to address the challenges facing the market, such as the high cost of instruments and consumables, and the complexity of data analysis.
Advancements in Sequencing and Microarray Technologies
Sequencing and microarray technologies are key factors driving the growth of the Global Spatial Genomics and Transcriptomics Market. Both technologies play a crucial role in enabling researchers to study the organization and function of genes in specific tissues.
Sequencing technologies are being widely adopted in spatial genomics and transcriptomics to enable the identification of cell types and cell interactions in complex tissues, such as the brain, tumor microenvironments, and immune cells.
Spatially resolved microarray technologies, such as the Nanostring nCounter system, allow simultaneous detection of gene expression in individual cells or small tissue regions.
Increasing Adoption of Bioinformatics
Bioinformatics is a crucial factor driving the growth of the Global Spatial Genomics and Transcriptomics Market. Spatial genomics and transcriptomics generate large volumes of data, and the analysis and interpretation of this data require advanced computational tools and algorithms. Bioinformatics provides the necessary tools and techniques for the analysis and interpretation of spatial genomics and transcriptomics data.
The availability of bioinformatics tools is driving the development of new applications and products in spatial genomics and transcriptomics. Companies are developing software platforms and analysis tools that enable researchers to analyze and visualize spatial genomics and transcriptomics data, and to integrate this data with other types of genomic and proteomic data.
Recent Development
- 10x Genomics Visium Spatial Gene Expression SolutionLaunched in 2019, this solution enables the high-throughput analysis of geneexpression and tissue morphology in situ, allowing researchers to understandthe spatial organization of cells and tissues.
- NanoString GeoMx Digital Spatial ProfilerLaunched in2018, this platform provides high-resolution spatial profiling of RNA andprotein expression in tissues, enabling the characterization of complexcellular environments and the identification of disease biomarkers.
- Cartana Spatial Transcriptomics KitLaunched in 2020,this kit enables the capture and analysis of RNA expression data in situ,allowing researchers to study gene expression patterns within complex tissuestructures.
- Akoya Biosciences Phenoptics 2.0Launched in 2021,this imaging platform enables the multiplexed analysis of tissue samples,combining spatial profiling with phenotypic analysis to provide a morecomprehensive understanding of cellular function.
- Fluidigm Advanta Spatial TranscriptomicsLaunched in2019, this technology allows for the capture and analysis of RNA expressiondata in situ, providing high-resolution spatial information about geneexpression patterns in tissues.
Market Segmentation
Global Spatial Genomics and Transcriptomics market can be segmented by technique, product type, application, end user, and region. Based on the technique, the market can be divided into spatial transcriptomics and spatial genomics analysis. Based on product type, the market can be segmented into instruments, consumables, and software. Based on application, the market can be divided into Translational Research and Drug discovery & development. Based on end user, the market can be differentiated into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes.
Market Players
10X Genomics Inc.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | By Technique By Product Type By Application By End User By Region |
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
Key companies profiled | 10X Genomics Inc., Akoya Bioscience Ltd., Biospyder Technologies Inc., BioTechne Corporation., Dovetail Genomics LLC., Fluidigm Corporation., Genomic Vision SA., Illumina Inc., Lunaphore Technologies SA., Nanostring Technolgies Inc |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |